What is it about?
Due to the increased degree of modulation and complexity of VMAT plans, it is necessary to have a pre-treatment patient-specific quality assurance (QA) program. The gamma index is commonly used to quantitatively compare two dose distributions. In this study we investigated the sensitivity of single- and multi-gamma criteria techniques to detect MLC positioning errors using the Varian TrueBeam Electronic Portal Imaging DeviceTM (EPID) dosimetry and the ArcCHECKTM device. The Varian TrueBeam EPID dosimetry shows a higher sensitivity in detecting MLC positioning errors compared to the ArcCHECK regardless of using the single- or the multi-gamma criteria techniques. Higher sensitivity was observed using the multi-gamma criteria technique compared to the single-criterion technique when using the EPID.
Featured Image
Read the Original
This page is a summary of: The sensitivity of gamma index analysis to detect multileaf collimator (MLC) positioning errors using Varian TrueBeam EPID and ArcCHECK for patient-specific prostate volumetric-modulated arc therapy (VMAT) quality assurance, Journal of Radiotherapy in Practice, July 2017, Cambridge University Press,
DOI: 10.1017/s1460396917000425.
You can read the full text:
Contributors
The following have contributed to this page







